Exogenous vs Endogenous Insulin Delivery: 2025 (original) (raw)

• Leslie RD, Evans-Molina C, Freund-Brown J, et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care. 2021;44(11):2449–56. https://doi.org/10.2337/dc21-0770.
  Article PubMed PubMed Central Google Scholar
• Powers AC. Type 1 diabetes mellitus: much progress, many opportunities. J Clin Invest. 2021;131(8)https://doi.org/10.1172/JCI142242
• Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the “accelerator hypothesis” (2). Diabet Med. 2005;22(2):144–51. https://doi.org/10.1111/j.1464-5491.2004.01368.x.
  Article PubMed Google Scholar
• Kibirige M, Metcalf B, Renuka R, Wilkin TJ. Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care. 2003;26(10):2865–70. https://doi.org/10.2337/diacare.26.10.2865.
  Article PubMed Google Scholar
• Knip M, Reunanen A, Virtanen SM, Nuutinen M, Viikari J, Akerblom HK. Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes? Pediatr Diabetes. 2008;9(3 Pt 2):46–9. https://doi.org/10.1111/j.1399-5448.2007.00344.x.
  Article PubMed Google Scholar
• Ljungkrantz M, Ludvigsson J, Samuelsson U. Type 1 diabetes: increased height and weight gains in early childhood. Pediatr Diabetes. 2008;9(3 Pt 2):50–6. https://doi.org/10.1111/j.1399-5448.2007.00360.x.
  Article PubMed Google Scholar
• Ludvigsson J. Why diabetes incidence increases–a unifying theory. Ann N Y Acad Sci. 2006;1079:374–82. https://doi.org/10.1196/annals.1375.058.
  Article PubMed Google Scholar
• Vella S, Bezzina Sultana M, Fava S. Association of cholesterol and lifestyle markers with type 1 diabetes incidence rates at a population level. J Public Health (Oxf). 2017;39(3):542–8. https://doi.org/10.1093/pubmed/fdw081.
  Article PubMed Google Scholar
• Viner RM, Hindmarsh PC, Taylor B, Cole TJ. Childhood body mass index (BMI), breastfeeding and risk of Type 1 diabetes: findings from a longitudinal national birth cohort. Diabet Med. 2008;25(9):1056–61. https://doi.org/10.1111/j.1464-5491.2008.02525.x.
  Article PubMed Google Scholar
• Lucier J, Weinstock RS. Type 1 Diabetes. StatPearls. 2024.
• Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N. Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes. Lancet Diabetes Endocrinol. 2020;8(5):436–46. https://doi.org/10.1016/S2213-8587(20)30042-5.
  Article PubMed Google Scholar
• Gregory GA, Robinson TIG, Linklater SE, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741–60. https://doi.org/10.1016/S2213-8587(22)00218-2.
  Article PubMed Google Scholar
• National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Centers for Disease Control and Prevention. Updated November 29, 2023. Accessed April 20, 2024, 2024. https://www.cdc.gov/diabetes/data/statistics-report/index.html
• Ogle GD, Gregory GA, Wang F, et al. The T1D Index: Implications of Initial Results, Data Limitations, and Future Development. Curr Diab Rep. 2023;23(10):277–91. https://doi.org/10.1007/s11892-023-01520-4.
  Article PubMed PubMed Central Google Scholar
• Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2015;3(4):151–5.
  Article Google Scholar
• Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266. https://doi.org/10.1016/j.coi.2022.102266.
  Article PubMed Google Scholar
• Murray M. Guest Blog: A Major Health Crisis: The Alarming Rise of Autoimmune Disease. National Health Council. Accessed December 9, 2024. https://nationalhealthcouncil.org/blog/a-major-health-crisis-the-alarming-rise-of-autoimmune-disease/
• Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45. https://doi.org/10.1542/peds.2013-2795.
  Article PubMed PubMed Central Google Scholar
• Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract. 1995;28(3):173–7. https://doi.org/10.1016/0168-8227(95)01092-r.
  Article PubMed Google Scholar
• Kesavadev J, Saboo B, Krishna MB, Krishnan G. Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas. Diabetes Ther. 2020;11(6):1251–69. https://doi.org/10.1007/s13300-020-00831-z.
  Article PubMed PubMed Central Google Scholar
• Masierek M, Nabrdalik K, Janota O, Kwiendacz H, Macherski M, Gumprecht J. The Review of Insulin Pens-Past, Present, and Look to the Future. Front Endocrinol (Lausanne). 2022;13:827484. https://doi.org/10.3389/fendo.2022.827484.
  Article PubMed Google Scholar
• Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z. Advances in transdermal insulin delivery. Adv Drug Deliv Rev. 2019;139:51–70. https://doi.org/10.1016/j.addr.2018.12.006.
  Article PubMed Google Scholar
• American Diabetes A. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care. 202;44(Suppl 1):S73-S84. https://doi.org/10.2337/dc21-S006
• Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40(12):1631–40. https://doi.org/10.2337/dc17-1600.
  Article PubMed PubMed Central Google Scholar
• Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400–5. https://doi.org/10.2337/dc18-1444.
  Article PubMed Google Scholar
• Feng ZQ, Guo QY, Wang W, et al. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes. Diabetol Metab Syndr. 2021;13(1):119. https://doi.org/10.1186/s13098-021-00739-z.
  Article PubMed PubMed Central Google Scholar
• Lu J, Wang C, Shen Y, et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care. 2021;44(2):549–55. https://doi.org/10.2337/dc20-1862.
  Article PubMed Google Scholar
• El Malahi A, Van Elsen M, Charleer S, et al. Relationship between time in range, glycemic variability, HbA1c, and complications in adults with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2022;107(2):e570–81. https://doi.org/10.1210/clinem/dgab688.
  Article PubMed Google Scholar
• Advani A. Positioning time in range in diabetes management. Diabetologia. 2020;63(2):242–52. https://doi.org/10.1007/s00125-019-05027-0.
  Article PubMed Google Scholar
• Pettus JH, Zhou FL, Shepherd L, et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: a real-world study. Diabetes Care. 2019;42(12):2220–7. https://doi.org/10.2337/dc19-0830.
  Article PubMed Google Scholar
• Gomez-Peralta F, Menendez E, Conde S, et al. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study. Endocrinol Diabetes Nutr (Engl Ed). 2021;68(9):642–653. https://doi.org/10.1016/j.endien.2021.11.020
• Pines Corrales PJ, Arias Lozano C, Jimenez Martinez C, et al. Prevalence of severe hypoglycemia in a cohort of patients with type 1 diabetes. Endocrinol Diabetes Nutr (Engl Ed). 2021;68(1):47–52. https://doi.org/10.1016/j.endinu.2020.01.002.
  Article PubMed Google Scholar
• Alwafi H, Alsharif AA, Wei L, et al. Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2020;170:108522. https://doi.org/10.1016/j.diabres.2020.108522.
  Article PubMed Google Scholar
• Martinez-Ortega AJ, Munoz-Gomez C, Gros-Herguido N, et al. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia. J Clin Med. 2022;11(4) https://doi.org/10.3390/jcm11041039
• Ashrafzadeh S, Hamdy O. Patient-Driven Diabetes Care of the Future in the Technology Era. Cell Metab. 2019;29(3):564–75. https://doi.org/10.1016/j.cmet.2018.09.005.
  Article PubMed Google Scholar
• Di Molfetta S, Caruso I, Cignarelli A, et al. Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab. 2023;25(5):1301–10. https://doi.org/10.1111/dom.14981.
  Article PubMed Google Scholar
• Edelman SV, Argento NB, Pettus J, Hirsch IB. Clinical implications of real-time and intermittently scanned continuous glucose monitoring. Diabetes Care. 2018;41(11):2265–74. https://doi.org/10.2337/dc18-1150.
  Article PubMed Google Scholar
• Leelarathna L, Evans ML, Neupane S, et al. Intermittently scanned continuous glucose monitoring for type 1 diabetes. N Engl J Med. 2022;387(16):1477–87. https://doi.org/10.1056/NEJMoa2205650.
  Article PubMed Google Scholar
• Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the gold randomized clinical trial. JAMA. 2017;317(4):379–87. https://doi.org/10.1001/jama.2016.19976.
  Article PubMed Google Scholar
• Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347–59. https://doi.org/10.1016/S0140-6736(17)32400-5.
  Article PubMed PubMed Central Google Scholar
• Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391(10128):1367–77. https://doi.org/10.1016/S0140-6736(18)30297-6.
  Article PubMed Google Scholar
• Youngkin EM, Majidi S, Noser AE, Stanek KR, Clements MA, Patton SR. Continuous Glucose Monitoring Decreases Hypoglycemia Avoidance Behaviors, but Not Worry in Parents of Youth With New Onset Type 1 Diabetes. J Diabetes Sci Technol. 2021;15(5):1093–7. https://doi.org/10.1177/1932296820929420.
  Article PubMed Google Scholar
• Tauschmann M, Hermann JM, Freiberg C, et al. Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3,553 subjects from the dpv registry. Diabetes Care. 2020;43(3):e40–2. https://doi.org/10.2337/dc19-1358.
  Article PubMed Google Scholar
• Moon SJ, Jung I, Park CY. Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence. Diabetes Metab J. 2021;45(6):813–39. https://doi.org/10.4093/dmj.2021.0177.
  Article PubMed PubMed Central Google Scholar
• Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310(12):1240–7. https://doi.org/10.1001/jama.2013.277818.
  Article PubMed Google Scholar
• Wilmot EG, Danne T. DIY artificial pancreas systems: the clinician perspective. Lancet Diabetes Endocrinol. 2020;8(3):183–5. https://doi.org/10.1016/S2213-8587(19)30416-4.
  Article PubMed Google Scholar
• Cacoub P, Vautier M, Desbois AC, Saadoun D, Younossi Z. Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France. Aliment Pharmacol Ther. 2018;47(1):123–8. https://doi.org/10.1111/apt.14382.
  Article PubMed Google Scholar
• Gruessner RW, Gruessner AC. Pancreas transplant alone: a procedure coming of age. Diabetes Care. 2013;36(8):2440–7. https://doi.org/10.2337/dc12-2195.
  Article PubMed PubMed Central Google Scholar
• Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant. 2004;4(12):2018–26. https://doi.org/10.1111/j.1600-6143.2004.00667.x.
  Article PubMed Google Scholar
• Gruessner RW, Sutherland DE, Kandaswamy R, Gruessner AC. Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation. 2008;85(1):42–7. https://doi.org/10.1097/01.tp.0000296820.46978.3f.
  Article PubMed Google Scholar
• Jarmi T, Brennan E, Clendenon J, Spaulding AC. Mortality assessment for pancreas transplants in the United States over the decade 2008–2018. World J Transplant. 2023;13(4):147–56. https://doi.org/10.5500/wjt.v13.i4.147.
  Article PubMed PubMed Central Google Scholar
• Rana A, Gruessner A, Agopian VG, et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015;150(3):252–9. https://doi.org/10.1001/jamasurg.2014.2038.
  Article PubMed Google Scholar
• Sollinger HW, Odorico JS, Becker YT, D’Alessandro AM, Pirsch JD. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg. 2009;250(4):618–30. https://doi.org/10.1097/SLA.0b013e3181b76d2b.
  Article PubMed Google Scholar
• Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg. 2001;233(4):463–501. https://doi.org/10.1097/00000658-200104000-00003.
  Article PubMed PubMed Central Google Scholar
• Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA. 2003;290(21):2817–23. https://doi.org/10.1001/jama.290.21.2817.
  Article PubMed Google Scholar
• Ojo AO, Meier-Kriesche HU, Hanson JA, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation. 2001;71(1):82–90. https://doi.org/10.1097/00007890-200101150-00014.
  Article PubMed Google Scholar
• Fridell JA, Niederhaus S, Curry M, Urban R, Fox A, Odorico J. The survival advantage of pancreas after kidney transplant. Am J Transplant. 2019;19(3):823–30. https://doi.org/10.1111/ajt.15106.
  Article PubMed Google Scholar
• Rayhill SC, D’Alessandro AM, Odorico JS, et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg. 2000;231(3):417–23. https://doi.org/10.1097/00000658-200003000-00015.
  Article PubMed PubMed Central Google Scholar
• Reddy KS, Stablein D, Taranto S, et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis. 2003;41(2):464–70. https://doi.org/10.1053/ajkd.2003.50057.
  Article PubMed Google Scholar
• Young BY, Gill J, Huang E, et al. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol. 2009;4(4):845–52. https://doi.org/10.2215/CJN.02250508.
  Article PubMed PubMed Central Google Scholar
• Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM. Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol. 2003;14(1):208–13. https://doi.org/10.1097/01.asn.0000037678.54984.41.
  Article PubMed Google Scholar
• Ji M, Wang M, Hu W, et al. Survival after simultaneous pancreas-kidney transplantation in type 1 diabetes: the critical role of early pancreas allograft function. Transpl Int. 2022;35:10618. https://doi.org/10.3389/ti.2022.10618.
  Article PubMed PubMed Central Google Scholar
• Poommipanit N, Sampaio MS, Cho Y, et al. Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database. Transplantation. 2010;89(12):1496–503. https://doi.org/10.1097/TP.0b013e3181dd3587.
  Article PubMed Google Scholar
• Weiss AS, Smits G, Wiseman AC. Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol. 2009;4(5):988–95. https://doi.org/10.2215/CJN.04940908.
  Article PubMed PubMed Central Google Scholar
• Sung RS, Zhang M, Schaubel DE, Shu X, Magee JC. A reassessment of the survival advantage of simultaneous kidney-pancreas versus kidney-alone transplantation. Transplantation. 2015;99(9):1900–6. https://doi.org/10.1097/TP.0000000000000663.
  Article PubMed PubMed Central Google Scholar
• Coppelli A, Giannarelli R, Mariotti R, et al. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation. 2003;76(6):974–6. https://doi.org/10.1097/01.TP.0000084202.18999.1D.
  Article PubMed Google Scholar
• Kim SJ, Smail N, Paraskevas S, Schiff J, Cantarovich M. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease. Transplantation. 2014;97(6):675–80. https://doi.org/10.1097/01.TP.0000437556.87109.45.
  Article PubMed Google Scholar
• Nata N, Huang E, Kamgar M, et al. Kidney failure requiring kidney transplantation after pancreas transplant alone. Clin Transpl. 2013:45–52.
• Scalea JR, Butler CC, Munivenkatappa RB, et al. Pancreas transplant alone as an independent risk factor for the development of renal failure: a retrospective study. Transplantation. 2008;86(12):1789–94. https://doi.org/10.1097/TP.0b013e3181913fbf.
  Article PubMed Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–8. https://doi.org/10.1056/NEJM200007273430401.
  Article PubMed Google Scholar
• Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339(2):69–75. https://doi.org/10.1056/NEJM199807093390202.
  Article PubMed Google Scholar
• Kaur RJ, Mujtahedi SS, Fridell JA, et al. Impact of pancreas transplantation alone on kidney function: A multicenter clinical cohort study. Clin Transplant. 2024;38(1):e15212. https://doi.org/10.1111/ctr.15212.
  Article PubMed Google Scholar
• Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2016;39(7):1230–40. https://doi.org/10.2337/dc15-1988.
  Article PubMed PubMed Central Google Scholar
• Marfil-Garza BA, Imes S, Verhoeff K, et al. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada. Lancet Diabetes Endocrinol. 2022;10(7):519–32. https://doi.org/10.1016/S2213-8587(22)00114-0.
  Article PubMed Google Scholar
• Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318–30. https://doi.org/10.1056/NEJMoa061267.
  Article PubMed Google Scholar
• Markmann JF, Rickels MR, Eggerman TL, et al. Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. Am J Transplant. 2021;21(4):1477–92. https://doi.org/10.1111/ajt.16174.
  Article PubMed Google Scholar
• Lablanche S, Vantyghem MC, Kessler L, et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2018;6(7):527–37. https://doi.org/10.1016/S2213-8587(18)30078-0.
  Article PubMed Google Scholar
• Group CR. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR). Cell Transplant. 2009;18(7):753–67. https://doi.org/10.3727/096368909X470874.
  Article Google Scholar
• Vantyghem MC, Chetboun M, Gmyr V, et al. Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study. Diabetes Care. 2019;42(11):2042–9. https://doi.org/10.2337/dc19-0401.
  Article PubMed Google Scholar
• Lablanche S, Borot S, Wojtusciszyn A, et al. Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network. Am J Transplant. 2021;21(11):3725–33. https://doi.org/10.1111/ajt.16637.
  Article PubMed Google Scholar
• Rickels MR, Eggerman TL, Bayman L, et al. Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the clinical islet transplantation consortium: the CIT-08 study. Diabetes Care. 2022;45(12):2967–75. https://doi.org/10.2337/dc21-2688.
  Article PubMed PubMed Central Google Scholar
• Chetboun M, Masset C, Maanaoui M, et al. Primary graft function and 5 year insulin independence after pancreas and islet transplantation for type 1 diabetes: a retrospective parallel cohort study. Transpl Int. 2023;36:11950. https://doi.org/10.3389/ti.2023.11950.
  Article PubMed PubMed Central Google Scholar
• Marfil-Garza BA, Hefler J, Verhoeff K, et al. Pancreas and islet transplantation: comparative outcome analysis of a single-centre cohort over 20-years. Ann Surg. 2023;277(4):672–80. https://doi.org/10.1097/SLA.0000000000005783.
  Article PubMed Google Scholar
• Gerber PA, Pavlicek V, Demartines N, et al. Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up. Diabetologia. 2008;51(1):110–9. https://doi.org/10.1007/s00125-007-0860-4.
  Article PubMed Google Scholar
• Lehmann R, Graziano J, Brockmann J, et al. Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up. Diabetes Care. 2015;38(5):752–9. https://doi.org/10.2337/dc14-1686.
  Article PubMed Google Scholar
• Frank A, Deng S, Huang X, et al. Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg. 2004;240(4):631–40. https://doi.org/10.1097/01.sla.0000140754.26575.2a.
  Article PubMed PubMed Central Google Scholar
• Maffi P, Scavini M, Socci C, et al. Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. Rev Diabet Stud. Spring 2011;8(1):44–50. https://doi.org/10.1900/RDS.2011.8.44
• Nathan DM, Group DER. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9-16. https://doi.org/10.2337/dc13-2112
• Diabetes C, Complications Trial Research G, Nathan DM, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. https://doi.org/10.1056/NEJM199309303291401
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–53.
• Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med. 1998;128(7):517–23. https://doi.org/10.7326/0003-4819-128-7-199804010-00001
• The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968–83.
• Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53. https://doi.org/10.1056/NEJMoa052187.
  Article PubMed Google Scholar
• Lin YK, Groat D, Chan O, et al. Associations between the time in hypoglycemia and hypoglycemia awareness status in type 1 diabetes patients using continuous glucose monitoring systems. Diabetes Technol Ther. 2020;22(11):787–93. https://doi.org/10.1089/dia.2020.0016.
  Article PubMed PubMed Central Google Scholar
• McCune K, Owen-Simon N, Dube GK, Ratner LE. The best insulin delivery is a human pancreas. Clin Transplant. 2023;37(4):e14920. https://doi.org/10.1111/ctr.14920.
  Article PubMed Google Scholar
• Rickels MR, Peleckis AJ, Markmann E, et al. Long-term improvement in glucose control and counterregulation by islet transplantation for type 1 diabetes. J Clin Endocrinol Metab. 2016;101(11):4421–30. https://doi.org/10.1210/jc.2016-1649.
  Article PubMed PubMed Central Google Scholar
• Coppelli A, Giannarelli R, Vistoli F, et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care. 2005;28(6):1366–70. https://doi.org/10.2337/diacare.28.6.1366.
  Article PubMed Google Scholar
• Ramsay RC, Goetz FC, Sutherland DE, et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med. 1988;318(4):208–14. https://doi.org/10.1056/NEJM198801283180403.
  Article PubMed Google Scholar
• Helve J, Sund R, Arffman M, et al. Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes. Diabetes Care. 2018;41(3):434–9. https://doi.org/10.2337/dc17-2364.
  Article PubMed Google Scholar
• Dholakia S, Oskrochi Y, Easton G, Papalois V. Advances in pancreas transplantation. J R Soc Med. 2016;109(4):141–6. https://doi.org/10.1177/0141076816636369.
  Article PubMed PubMed Central Google Scholar
• Gruessner AC. a decade of pancreas transplantation—a registry report. Uro. 2023;3(2):132–50.
  Article Google Scholar